Baseline demographics and treatment received
| . | Value . |
|---|---|
| Baseline demographics | |
| Age, y | |
| Median | 30 |
| Range | 1-94 |
| Sex, % | |
| Male | 38 |
| Female | 62 |
| Prior treatments received, no. (%) | |
| Steroid | 406 (52) |
| IVIG | 399 (52) |
| Intravenous anti-D | 277 (36) |
| Steroids and IVIG | 292 (38) |
| Steroids and intravenous anti-D | 201 (26) |
| Steroids, IVIG, and intravenous anti-D | 161 (21) |
| Ig levels, mg/dL | |
| IgA median | 166 |
| IgA range | 6.6-1535 |
| IgM median | 114 |
| IgM range | 7-1550 |
| IgG median | 1120 |
| IgG range | 128-6710 |
| Subjects with abnormal Ig | |
| Elevated IgA, no. (%) | 107 (14) |
| Low IgA, no. (%) | 114 (15) |
| Elevated IgM, no. (%) | 29 (4) |
| Low IgM, no. (%) | 85 (11) |
| Elevated IgG, no. (%) | 245 (32) |
| Low IgG, no. (%) | 66 (9) |
| . | Value . |
|---|---|
| Baseline demographics | |
| Age, y | |
| Median | 30 |
| Range | 1-94 |
| Sex, % | |
| Male | 38 |
| Female | 62 |
| Prior treatments received, no. (%) | |
| Steroid | 406 (52) |
| IVIG | 399 (52) |
| Intravenous anti-D | 277 (36) |
| Steroids and IVIG | 292 (38) |
| Steroids and intravenous anti-D | 201 (26) |
| Steroids, IVIG, and intravenous anti-D | 161 (21) |
| Ig levels, mg/dL | |
| IgA median | 166 |
| IgA range | 6.6-1535 |
| IgM median | 114 |
| IgM range | 7-1550 |
| IgG median | 1120 |
| IgG range | 128-6710 |
| Subjects with abnormal Ig | |
| Elevated IgA, no. (%) | 107 (14) |
| Low IgA, no. (%) | 114 (15) |
| Elevated IgM, no. (%) | 29 (4) |
| Low IgM, no. (%) | 85 (11) |
| Elevated IgG, no. (%) | 245 (32) |
| Low IgG, no. (%) | 66 (9) |